Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Common Equity (2016 - 2025)

Cross Country Healthcare's Common Equity history spans 16 years, with the latest figure at $322.8 million for Q4 2025.

  • For Q4 2025, Common Equity fell 22.95% year-over-year to $322.8 million; the TTM value through Dec 2025 reached $322.8 million, down 22.95%, while the annual FY2025 figure was $322.8 million, 22.95% down from the prior year.
  • Common Equity reached $322.8 million in Q4 2025 per CCRN's latest filing, down from $408.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $467.7 million in Q4 2023 to a low of $173.7 million in Q1 2021.
  • Average Common Equity over 5 years is $383.3 million, with a median of $418.6 million recorded in 2024.
  • Peak YoY movement for Common Equity: surged 113.82% in 2022, then fell 22.95% in 2025.
  • A 5-year view of Common Equity shows it stood at $294.3 million in 2021, then skyrocketed by 53.43% to $451.5 million in 2022, then increased by 3.58% to $467.7 million in 2023, then decreased by 10.41% to $419.0 million in 2024, then fell by 22.95% to $322.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCRN's Common Equity are $322.8 million (Q4 2025), $408.1 million (Q3 2025), and $412.2 million (Q2 2025).